Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec 18:8:159.
doi: 10.3389/fnana.2014.00159. eCollection 2014.

Alpha-synuclein spreading in Parkinson's disease

Affiliations
Review

Alpha-synuclein spreading in Parkinson's disease

Ariadna Recasens et al. Front Neuroanat. .

Abstract

Formation and accumulation of misfolded protein aggregates are a central hallmark of several neurodegenerative diseases. In Parkinson's disease (PD), the aggregation-prone protein alpha-synuclein (α-syn) is the culprit. In the past few years, another piece of the puzzle has been added with data suggesting that α-syn may self-propagate, thereby contributing to the progression and extension of PD. Of particular importance, it was the seminal observation of Lewy bodies (LB), a histopathological signature of PD, in grafted fetal dopaminergic neurons in the striatum of PD patients. Consequently, these findings were a conceptual breakthrough, generating the "host to graft transmission" hypothesis, also called the "prion-like hypothesis." Several in vitro and in vivo studies suggest that α-syn can undergo a toxic templated conformational change, spread from cell to cell and from region to region, and initiate the formation of "LB-like aggregates," contributing to the PD pathogenesis. Here, we will review and discuss the current knowledge for such a putative mechanism on the prion-like nature of α-syn, and discuss about the proper use of the term prion-like.

Keywords: Parkinson disease; aggregation; neurodegenerative diseases; spreading; α-synuclein.

PubMed Disclaimer

References

    1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W. H., Castillo P. E., et al. (2000). Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 239–252 10.1016/S0896-6273(00)80886-7 - DOI - PubMed
    1. Ahn K. J., Paik S. R., Chung K. C., Kim J. (2006). Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J. Neurochem. 97 265–279 10.1111/j.1471-4159.2006.03731.x - DOI - PubMed
    1. Alafuzoff I., Ince P. G., Arzberger T., Al-Sarraj S., Bell J., Bodi I., et al. (2009). Staging/typing of lewy body related alpha-synuclein pathology: a study of the brainnet Europe consortium. Acta Neuropathol. 117 635–652 10.1007/s00401-009-0523-2 - DOI - PubMed
    1. Alvarez-Erviti L., Couch Y., Richardson J., Cooper J. M., Wood M. J. (2011a). Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci. Res. 69 337–342 10.1016/j.neures.2010.12.020 - DOI - PubMed
    1. Alvarez-Erviti L., Seow Y., Schapira A. H., Gardiner C., Sargent I. L., Wood M. J., et al. (2011b). Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol. Dis. 42 360–367 10.1016/j.nbd.2011.01.029 - DOI - PMC - PubMed